Improvement plan for Domestic biosimilar drug assessment to be finalized

As the government included the biopharmaceutical industry in the target for the relaxation policy of regulation, the Ministry of Health and Welfare(MOHW) is planning to finalize the improvement plan for drug price assessment of biosimilars soon.

Based on the government’s relaxation policy of regulation, the MOHW has reviewed improvement on the biosimilar drug price assessment, and was recently...